These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16816403)

  • 1. AKT-independent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2alpha.
    Arvisais EW; Romanelli A; Hou X; Davis JS
    J Biol Chem; 2006 Sep; 281(37):26904-13. PubMed ID: 16816403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase.
    Arvisais E; Hou X; Wyatt TA; Shirasuna K; Bollwein H; Miyamoto A; Hansen TR; Rueda BR; Davis JS
    Mol Endocrinol; 2010 Mar; 24(3):632-43. PubMed ID: 20160123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase.
    Hou X; Arvisais EW; Davis JS
    Endocrinology; 2010 Jun; 151(6):2846-57. PubMed ID: 20351317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK1/2 is involved in luteal cell autophagy regulation during corpus luteum regression via an mTOR-independent pathway.
    Choi J; Jo M; Lee E; Choi D
    Mol Hum Reprod; 2014 Oct; 20(10):972-80. PubMed ID: 25107837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin F2alpha stimulates the Raf/MEK1/mitogen-activated protein kinase signaling cascade in bovine luteal cells.
    Chen DB; Westfall SD; Fong HW; Roberson MS; Davis JS
    Endocrinology; 1998 Sep; 139(9):3876-85. PubMed ID: 9724043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of c-fos and c-jun messenger ribonucleic acid expression by prostaglandin F2alpha is mediated by a protein kinase C-dependent extracellular signal-regulated kinase mitogen-activated protein kinase pathway in bovine luteal cells.
    Chen D; Fong HW; Davis JS
    Endocrinology; 2001 Feb; 142(2):887-95. PubMed ID: 11159862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
    Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
    J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin F2alpha stimulates the expression and secretion of transforming growth factor B1 via induction of the early growth response 1 gene (EGR1) in the bovine corpus luteum.
    Hou X; Arvisais EW; Jiang C; Chen DB; Roy SK; Pate JL; Hansen TR; Rueda BR; Davis JS
    Mol Endocrinol; 2008 Feb; 22(2):403-14. PubMed ID: 17916653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.
    Iijima Y; Laser M; Shiraishi H; Willey CD; Sundaravadivel B; Xu L; McDermott PJ; Kuppuswamy D
    J Biol Chem; 2002 Jun; 277(25):23065-75. PubMed ID: 11940578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
    Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
    J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
    Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth.
    Gan B; Yoo Y; Guan JL
    J Biol Chem; 2006 Dec; 281(49):37321-9. PubMed ID: 17043358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent.
    Karbowniczek M; Cash T; Cheung M; Robertson GP; Astrinidis A; Henske EP
    J Biol Chem; 2004 Jul; 279(29):29930-7. PubMed ID: 15150271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells.
    Kayampilly PP; Menon KM
    Endocrinology; 2007 Aug; 148(8):3950-7. PubMed ID: 17510244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.
    Hahn-Windgassen A; Nogueira V; Chen CC; Skeen JE; Sonenberg N; Hay N
    J Biol Chem; 2005 Sep; 280(37):32081-9. PubMed ID: 16027121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin is activated in association with myometrial proliferation during pregnancy.
    Jaffer S; Shynlova O; Lye S
    Endocrinology; 2009 Oct; 150(10):4672-80. PubMed ID: 19589861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.